Skip to content
OpenCapital
Get started

Vericel VCEL Proceeds from disposition of marketable securities and other investments

Proceeds from disposition of marketable securities and other investments at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$209M-4.1%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%—

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's proceeds from disposition of marketable securities and other investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's proceeds from disposition of marketable securities and other investments?
Vericel (VCEL) reported proceeds from disposition of marketable securities and other investments of $14.25M in Q1 2026.
How has Vericel's proceeds from disposition of marketable securities and other investments changed year-over-year?
Vericel's proceeds from disposition of marketable securities and other investments increased by 14.0% year-over-year, from $12.5M to $14.25M.
What is the long-term trend for Vericel's proceeds from disposition of marketable securities and other investments?
Over 4 years (2021 to 2025), Vericel's proceeds from disposition of marketable securities and other investments has grown at a -3.6% compound annual growth rate (CAGR), from $64.44M to $55.6M.